Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ViraTherapeutics starts Series A round with €3.6mm

Executive Summary

ViraTherapeutics GMBH (oncolytic virus-based immunotherapies for cancer) began its Series A round with a €3.6mm ($4mm) investment from co-leads Boehringer Ingelheim Venture Fund and EMBL Ventures (which both take board seats), along with Austria Wirtschaftsservice, through its Venture Capital Initiative.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies